Results 61 to 70 of about 6,390 (108)

Utilizing the VISIA Camera for Analyzing 5-Fluorouracil Treatment Efficacy for Actinic Keratosis. [PDF]

JMIR Dermatol
Woolhiser E, Jamal L, Kirk J, Baum B, Dellavalle R.   +4 more
europepmc   +1 more source

Efficacy and safety of risk-stratified chemotherapy with azacitidine for children with myeloid leukaemia with Down syndrome: protocol for a multicentre phase II trial (JCCG AML-D24). [PDF]

BMJ Open
Nakashima K, Hasegawa D, Matsubayashi J, Tanaka S, Hama A, Yamato G, Kato S, Honda M, Nagai K, Goto H, Tsujimoto SI, Deguchi T, Niwa K, Hiramatsu H, Terui K, Toki T, Yoshida K, Kawai T, Saito AM, Moritake H, Taga T, Okamoto Y, Koh K, Tomizawa D.   +23 more
europepmc   +1 more source

Exceptional long-term survival in a patient with recurrent pancreatic carcinoma on adjuvant tegafur-gimeracil-oteracil potassium: a case report. [PDF]

J Med Case Rep
Sim NE, Ho GF.
europepmc   +1 more source

Comparable efficacy of extraoral and intraoral photobiomodulation in preventing oral mucositis during high-dose methotrexate therapy in pediatric oncology: A single-blind randomized controlled trial. [PDF]

Support Care Cancer
Freitas IOP, Schuartz I, Renz GLK, Mobile RZ, França MLS, Pianovski MAD, Sassi LM, de Araujo MR.   +7 more
europepmc   +1 more source

Integrated analyses identify MAN1B1 as a candidate regulator of chemotherapeutic tolerance and immunosuppression in bladder cancer. [PDF]

Front Immunol
Jiang M, Zhao D, Zhang L, Zhu D, Li J, Zheng Z.   +5 more
europepmc   +1 more source

The NUDIX hydrolase NUDT5 influences purine nucleotide metabolism and thiopurine pharmacology. [PDF]

J Clin Invest
Kager L, Boztug K.
europepmc   +1 more source

Mitochondrial Genomic Alterations in Pediatric Acute Lymphoblastic Leukemia: Implications for Methotrexate-Induced Neurotoxicity and Ethnic Disparities. [PDF]

Cancer Med
Han J, Arsang-Jang S, Auer PL, Saber W, Michaelis L, Urrutia R, Gai X, Lupo P, Scheurer M, Dong J.   +9 more
europepmc   +1 more source

PIP4K2A depletion suppresses AKT signaling and enhances chemotherapy sensitivity in T-cell lymphoblastic lymphoma cells. [PDF]

Biochem Biophys Res Commun
Chen S, He Z, Ha Y.
europepmc   +1 more source

Prior therapy defines mutation profiles in childhood cancer at relapse. [PDF]

Nature
Layeghifard M, Díaz-Gay M, Bergstrom EN, Mahendralingam MJ, Light N, Blay S, Nash JO, Anderson ND, Au JN, Davidson S, Ballester PL, Wen T, Daud SK, Edward LM, Ashiqul Islam SM, Khandekar A, Otlu B, Brunga L, Hammad R, Nassif S, Thacker NH, Feltham T, Fuentes-Bolanos NA, Wong-Erasmus M, Levine MF, Miller KE, Shukla NN, Kinnaman MD, Glodzik D, Portwine C, Millson S, Zorzi AP, Mikhail M, Fernandez CV, Wheaton L, Gundem G, Kung AL, Tabori U, Mayoh C, Papaemmanuil E, Cowley MJ, Malkin D, Villani A, Alexandrov LB, Shlien A.   +44 more
europepmc   +1 more source

Haematological toxicity associated with antineoplastic drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database. [PDF]

Front Immunol
Xu X, Ma L.
europepmc   +1 more source